Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Prediction of significant estimated glomerular filtration rate decline after renal unit removal to aid in the clinical choice between radical and partial nephrectomy in patients with a renal mass and normal renal function.

McIntosh AG, Parker DC, Egleston BL, Uzzo RG, Haseebuddin M, Joshi SS, Viterbo R, Greenberg RE, Chen DYT, Smaldone MC, Kutikov A.

BJU Int. 2019 May 30. doi: 10.1111/bju.14839. [Epub ahead of print]

PMID:
31145523
2.

Perioperative Statin Use and Acute Kidney Injury in Patients Undergoing Partial Nephrectomy.

Joshi SS, Ruth K, Smaldone MC, Chen DYT, Greenberg RE, Viterbo R, Kutikov A, Uzzo RG.

Kidney Cancer. 2018 Mar 30;2(1):47-55. doi: 10.3233/KCA-180031.

3.

Incisional hernia after cystectomy: incidence, risk factors and anthropometric predisposition.

Edwards DC, Cahn DB, Reddy M, Kivlin D, Malhotra A, Li T, Chen DYT, Viterbo R, Uzzo RG, Greenberg RE, Smaldone MC, Curcillo P, Kutikov A.

Can J Urol. 2018 Dec;25(6):9573-9578.

PMID:
30553281
4.

Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-invasive Bladder Cancer: Results of a Phase 2 Trial.

Anari F, O'Neill J, Choi W, Chen DYT, Haseebuddin M, Kutikov A, Dulaimi E, Alpaugh RK, Devarajan K, Greenberg RE, Bilusic M, Wong YN, Viterbo R, Hoffman-Censits JH, Lallas CD, Trabulsi EJ, Smaldone M, Geynisman DM, Zibelman M, Lin J, Kelly WK, Uzzo R, McConkey D, Plimack ER.

Eur Urol Oncol. 2018 May;1(1):54-60. doi: 10.1016/j.euo.2018.02.007. Epub 2018 Jun 6.

5.

Renal Hilar Lesions: Biological Implications for Complex Partial Nephrectomy.

Correa AF, Yankey H, Li T, Joshi SS, Kutikov A, Chen DY, Viterbo R, Greenberg RE, Smaldone MC, Uzzo RG.

Urology. 2019 Jan;123:174-180. doi: 10.1016/j.urology.2018.08.044. Epub 2018 Oct 6.

PMID:
30296503
6.

NCCN Guidelines Insights: Bladder Cancer, Version 5.2018.

Flaig TW, Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Downs TM, Efstathiou JA, Friedlander T, Greenberg RE, Guru KA, Hahn N, Herr HW, Hoimes C, Inman BA, Jimbo M, Kader AK, Lele SM, Meeks JJ, Michalski J, Montgomery JS, Pagliaro LC, Pal SK, Patterson A, Petrylak DP, Plimack ER, Pohar KS, Porter MP, Preston MA, Sexton WJ, Siefker-Radtke AO, Tward J, Wile G, Johnson-Chilla A, Dwyer MA, Gurski LA.

J Natl Compr Canc Netw. 2018 Sep;16(9):1041-1053. doi: 10.6004/jnccn.2018.0072.

PMID:
30181416
7.

Active Surveillance for Localized Renal Masses: Tumor Growth, Delayed Intervention Rates, and >5-yr Clinical Outcomes.

McIntosh AG, Ristau BT, Ruth K, Jennings R, Ross E, Smaldone MC, Chen DYT, Viterbo R, Greenberg RE, Kutikov A, Uzzo RG.

Eur Urol. 2018 Aug;74(2):157-164. doi: 10.1016/j.eururo.2018.03.011. Epub 2018 Apr 4.

PMID:
29625756
8.

Treatment Trends and Outcomes for Patients With Lymph Node-Positive Cancer of the Penis.

Joshi SS, Handorf E, Strauss D, Correa AF, Kutikov A, Chen DYT, Viterbo R, Greenberg RE, Uzzo RG, Smaldone MC, Geynisman DM.

JAMA Oncol. 2018 May 1;4(5):643-649. doi: 10.1001/jamaoncol.2017.5608.

9.

Incremental yield of dysplasia detection in Barrett's esophagus using volumetric laser endomicroscopy with and without laser marking compared with a standardized random biopsy protocol.

Alshelleh M, Inamdar S, McKinley M, Stewart M, Novak JS, Greenberg RE, Sultan K, Devito B, Cheung M, Cerulli MA, Miller LS, Sejpal DV, Vegesna AK, Trindade AJ.

Gastrointest Endosc. 2018 Jul;88(1):35-42. doi: 10.1016/j.gie.2018.01.032. Epub 2018 Feb 2.

PMID:
29410080
10.

Differences in Survival Associated with Performance of Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database.

Correa AF, Handorf E, Joshi SS, Geynisman DM, Kutikov A, Chen DY, Uzzo RG, Viterbo R, Greenberg RE, Smaldone MC.

J Urol. 2018 May;199(5):1238-1244. doi: 10.1016/j.juro.2017.11.121. Epub 2017 Dec 15.

PMID:
29248557
11.

Endoscopic resection of an esophageal schwannoma.

Trindade AJ, Fan C, Cheung M, Greenberg RE.

Dig Liver Dis. 2018 Mar;50(3):309. doi: 10.1016/j.dld.2017.10.018. Epub 2017 Nov 2. No abstract available.

PMID:
29153489
12.

Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.

Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Clark PE, Downs TM, Efstathiou JA, Flaig TW, Friedlander T, Greenberg RE, Guru KA, Hahn N, Herr HW, Hoimes C, Inman BA, Jimbo M, Kader AK, Lele SM, Meeks JJ, Michalski J, Montgomery JS, Pagliaro LC, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Preston MA, Sexton WJ, Siefker-Radtke AO, Sonpavde G, Tward J, Wile G, Dwyer MA, Gurski LA.

J Natl Compr Canc Netw. 2017 Oct;15(10):1240-1267. doi: 10.6004/jnccn.2017.0156.

PMID:
28982750
13.

Contemporary practice patterns and survival outcomes for locally advanced urethral malignancies: A National Cancer Database Analysis.

Cahn DB, Handorf E, Ristau BT, Geynisman DM, Simhan J, Kutikov A, Greenberg RE, Viterbo R, Chen DYT, Uzzo RG, Smaldone MC.

Urol Oncol. 2017 Dec;35(12):670.e15-670.e21. doi: 10.1016/j.urolonc.2017.07.026. Epub 2017 Aug 10.

PMID:
28803701
14.

Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer.

Cahn DB, Handorf EA, Ghiraldi EM, Ristau BT, Geynisman DM, Churilla TM, Horwitz EM, Sobczak ML, Chen DYT, Viterbo R, Greenberg RE, Kutikov A, Uzzo RG, Smaldone MC.

Cancer. 2017 Nov 15;123(22):4337-4345. doi: 10.1002/cncr.30900. Epub 2017 Jul 25.

15.

WBC Associates with Readmission Following Cystectomy.

McIntosh AG, Li T, Ito T, Mannion J, Dziemianowicz M, Waingankar N, Haseebuddin M, Chen DYT, Greenberg RE, Viterbo R, Kutikov A, Uzzo RG, Smaldone MC, Abbosh PH.

Bladder Cancer. 2017 Apr 27;3(2):95-103. doi: 10.3233/BLC-160088.

16.

Long-Term Patient-Reported Outcomes From a Phase 3 Randomized Prospective Trial of Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer.

Shaikh T, Li T, Handorf EA, Johnson ME, Wang LS, Hallman MA, Greenberg RE, Price RA Jr, Uzzo RG, Ma C, Chen D, Geynisman DM, Pollack A, Horwitz EM.

Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):722-731. doi: 10.1016/j.ijrobp.2016.12.034. Epub 2016 Dec 28.

17.

Patient reported outcomes among treatment modalities for prostate cancer.

Johnson ME, Zaorsky NG, Martin JM, Ruth K, Greenberg RE, Uzzo RG, Hayes SB, Smaldone MC, Kutikov A, Viterbo R, Chen DY, Hallman MA, Sobczak ML, Horwitz EM.

Can J Urol. 2016 Dec;23(6):8535-8545.

PMID:
27995848
18.

Small-Cell Carcinoma of the Bladder: 20-Year Single-Institution Retrospective Review.

Jung K, Ghatalia P, Litwin S, Horwitz EM, Uzzo RG, Greenberg RE, Viterbo R, Geynisman DM, Kutikov A, Plimack ER, Smaldone MC, Wong YN, Bilusic M.

Clin Genitourin Cancer. 2017 Jun;15(3):e337-e343. doi: 10.1016/j.clgc.2016.09.005. Epub 2016 Sep 30. Review.

PMID:
27991416
19.

A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with FGFR3 Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157.

Hahn NM, Bivalacqua TJ, Ross AE, Netto GJ, Baras A, Park JC, Chapman C, Masterson TA, Koch MO, Bihrle R, Foster RS, Gardner TA, Cheng L, Jones DR, McElyea K, Sandusky GE, Breen T, Liu Z, Albany C, Moore ML, Loman RL, Reed A, Turner SA, De Abreu FB, Gallagher T, Tsongalis GJ, Plimack ER, Greenberg RE, Geynisman DM.

Clin Cancer Res. 2017 Jun 15;23(12):3003-3011. doi: 10.1158/1078-0432.CCR-16-2267. Epub 2016 Dec 8.

20.

NCCN Guidelines Insights: Bladder Cancer, Version 2.2016.

Clark PE, Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Efstathiou JA, Flaig TW, Friedlander T, Greenberg RE, Guru KA, Hahn N, Herr HW, Hoimes C, Inman BA, Kader AK, Kibel AS, Kuzel TM, Lele SM, Meeks JJ, Michalski J, Montgomery JS, Pagliaro LC, Pal SK, Patterson A, Petrylak D, Plimack ER, Pohar KS, Porter MP, Sexton WJ, Siefker-Radtke AO, Sonpavde G, Tward J, Wile G, Dwyer MA, Smith C.

J Natl Compr Canc Netw. 2016 Oct;14(10):1213-1224.

21.

Perioperative Outcomes Following Partial Nephrectomy Performed on Patients Remaining on Antiplatelet Therapy.

Ito T, Derweesh IH, Ginzburg S, Abbosh PH, Raheem OA, Mirheydar H, Hamilton Z, Chen DY, Smaldone MC, Greenberg RE, Viterbo R, Kutikov A, Uzzo RG.

J Urol. 2017 Jan;197(1):31-36. doi: 10.1016/j.juro.2016.07.001. Epub 2016 Jul 11.

PMID:
27418453
22.

The impact of trainee involvement on outcomes in low-dose-rate brachytherapy for prostate cancer.

Shaikh T, Wang L, Ruth K, Hallman M, Chen DY, Greenberg RE, Li J, Crawford K, Horwitz EM.

Brachytherapy. 2016 Mar-Apr;15(2):156-62. doi: 10.1016/j.brachy.2015.12.009. Epub 2016 Jan 29.

23.

Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid Features.

Ito T, Pei J, Dulaimi E, Menges C, Abbosh PH, Smaldone MC, Chen DY, Greenberg RE, Kutikov A, Viterbo R, Uzzo RG, Testa JR.

J Urol. 2016 Apr;195(4 Pt 1):852-8. doi: 10.1016/j.juro.2015.10.180. Epub 2015 Nov 18.

24.

Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer.

Plimack ER, Dunbrack RL, Brennan TA, Andrake MD, Zhou Y, Serebriiskii IG, Slifker M, Alpaugh K, Dulaimi E, Palma N, Hoffman-Censits J, Bilusic M, Wong YN, Kutikov A, Viterbo R, Greenberg RE, Chen DY, Lallas CD, Trabulsi EJ, Yelensky R, McConkey DJ, Miller VA, Golemis EA, Ross EA.

Eur Urol. 2015 Dec;68(6):959-67. doi: 10.1016/j.eururo.2015.07.009. Epub 2015 Aug 1.

25.

Residual Parenchymal Volume, Not Warm Ischemia Time, Predicts Ultimate Renal Functional Outcomes in Patients Undergoing Partial Nephrectomy.

Ginzburg S, Uzzo R, Walton J, Miller C, Kurz D, Li T, Handorf E, Gor R, Corcoran A, Viterbo R, Chen DY, Greenberg RE, Smaldone MC, Kutikov A.

Urology. 2015 Aug;86(2):300-5. doi: 10.1016/j.urology.2015.04.043. Epub 2015 Jul 18.

PMID:
26199171
26.

Use of Postprostatectomy Radiation Therapy at an NCI-Designated Comprehensive Cancer Center.

Martin JM, Li T, Johnson ME, Murphy CT, Howald AG, Smaldone MC, Kutikov A, Chen DY, Viterbo R, Greenberg RE, Uzzo RG, Horwitz EM.

J Natl Compr Canc Netw. 2015 May;13(5):525-30.

PMID:
25964638
27.

Surgical Apgar Score predicts an increased risk of major complications and death after renal mass excision.

Ito T, Abbosh PH, Mehrazin R, Tomaszewski JJ, Li T, Ginzburg S, Canter DJ, Greenberg RE, Viterbo R, Chen DY, Kutikov A, Smaldone MC, Uzzo RG.

J Urol. 2015 Jun;193(6):1918-22. doi: 10.1016/j.juro.2014.11.085. Epub 2014 Nov 18.

PMID:
25464000
28.

Is it necessary to perform week three dosimetric analysis in low-dose-rate brachytherapy for prostate cancer when day 0 dosimetry is done? A quality assurance assessment.

Shaikh T, Zaorsky NG, Ruth K, Chen DY, Greenberg RE, Li J, Crawford K, Horwitz EM.

Brachytherapy. 2015 May-Jun;14(3):316-21. doi: 10.1016/j.brachy.2014.09.012. Epub 2014 Nov 7.

29.

Is extended pharmacologic venous thromboembolism prophylaxis uniformly safe after radical cystectomy?

Mehrazin R, Piotrowski Z, Egleston B, Parker D, Tomaszweski JJ, Smaldone MC, Abbosh PH, Ito T, Bloch P, Iffrig K, Bilusic M, Chen DY, Viterbo R, Greenberg RE, Uzzo RG, Kutikov A.

Urology. 2014 Nov;84(5):1152-6. doi: 10.1016/j.urology.2014.06.058. Epub 2014 Oct 24.

30.

Tadalafil for erectile dysfunction prevention after radiotherapy for prostate cancer--reply.

Pisansky TM, Bruner DW, Greenberg RE.

JAMA. 2014 Aug 20;312(7):748-9. doi: 10.1001/jama.2014.7923. No abstract available.

PMID:
25138339
31.

EUS-guided botulinum toxin injection of the internal anal sphincter in anorectal outlet obstruction.

Trindade AJ, Hirten R, Greenberg RE, Sejpal DV.

Am J Gastroenterol. 2014 Aug;109(8):1293-4. doi: 10.1038/ajg.2014.138. No abstract available.

PMID:
25091252
32.

Internal validation of the renal pelvic score: a novel marker of renal pelvic anatomy that predicts urine leak after partial nephrectomy.

Tomaszewski JJ, Smaldone MC, Cung B, Li T, Mehrazin R, Kutikov A, Canter DJ, Viterbo R, Chen DY, Greenberg RE, Uzzo RG.

Urology. 2014 Aug;84(2):351-7. doi: 10.1016/j.urology.2014.05.001. Epub 2014 Jun 26.

33.

Patients with anatomically "simple" renal masses are more likely to be placed on active surveillance than those with anatomically "complex" lesions.

Tomaszewski JJ, Uzzo RG, Kocher N, Li T, Manley B, Mehrazin R, Ito T, Abbosh P, Viterbo R, Chen DY, Greenberg RE, Canter D, Smaldone MC, Kutikov A.

Urol Oncol. 2014 Nov;32(8):1267-71. doi: 10.1016/j.urolonc.2014.05.003. Epub 2014 Jun 7.

34.

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity.

Plimack ER, Hoffman-Censits JH, Viterbo R, Trabulsi EJ, Ross EA, Greenberg RE, Chen DY, Lallas CD, Wong YN, Lin J, Kutikov A, Dotan E, Brennan TA, Palma N, Dulaimi E, Mehrazin R, Boorjian SA, Kelly WK, Uzzo RG, Hudes GR.

J Clin Oncol. 2014 Jun 20;32(18):1895-901. doi: 10.1200/JCO.2013.53.2465. Epub 2014 May 12.

35.

Reply to M.J. Brenner et al and I.R. Vogelius et al.

Pollack A, Walker G, Horwitz EM, Price R, Feigenberg S, Konski AA, Stoyanova R, Movsas B, Greenberg RE, Uzzo RG, Ma C, Buyyounouski MK.

J Clin Oncol. 2014 Jun 10;32(17):1853-4. doi: 10.1200/JCO.2013.54.7729. Epub 2014 Apr 28. No abstract available.

PMID:
24778402
36.

Tadalafil for prevention of erectile dysfunction after radiotherapy for prostate cancer: the Radiation Therapy Oncology Group [0831] randomized clinical trial.

Pisansky TM, Pugh SL, Greenberg RE, Pervez N, Reed DR, Rosenthal SA, Mowat RB, Raben A, Buyyounouski MK, Kachnic LA, Bruner DW.

JAMA. 2014 Apr 2;311(13):1300-7. doi: 10.1001/jama.2014.2626.

37.

Assessing the burden of complications after surgery for clinically localized kidney cancer by age and comorbidity status.

Tomaszewski JJ, Uzzo RG, Kutikov A, Hrebinko K, Mehrazin R, Corcoran A, Ginzburg S, Viterbo R, Chen DY, Greenberg RE, Smaldone MC.

Urology. 2014 Apr;83(4):843-9. doi: 10.1016/j.urology.2013.12.048.

38.

Growth kinetics and short-term outcomes of cT1b and cT2 renal masses under active surveillance.

Mehrazin R, Smaldone MC, Kutikov A, Li T, Tomaszewski JJ, Canter DJ, Viterbo R, Greenberg RE, Chen DY, Uzzo RG.

J Urol. 2014 Sep;192(3):659-64. doi: 10.1016/j.juro.2014.03.038. Epub 2014 Mar 15.

39.

Renal pelvic anatomy is associated with incidence, grade, and need for intervention for urine leak following partial nephrectomy.

Tomaszewski JJ, Cung B, Smaldone MC, Mehrazin R, Kutikov A, Viterbo R, Chen DY, Greenberg RE, Uzzo RG.

Eur Urol. 2014 Nov;66(5):949-55. doi: 10.1016/j.eururo.2013.10.009. Epub 2013 Oct 26.

PMID:
24184023
40.

Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer.

Pollack A, Walker G, Horwitz EM, Price R, Feigenberg S, Konski AA, Stoyanova R, Movsas B, Greenberg RE, Uzzo RG, Ma C, Buyyounouski MK.

J Clin Oncol. 2013 Nov 1;31(31):3860-8. doi: 10.1200/JCO.2013.51.1972. Epub 2013 Oct 7.

41.

Comparison of prostate cancer diagnosis in patients receiving unrelated urological and non-urological cancer care.

Corcoran AT, Smaldone MC, Egleston BL, Simhan J, Ginzburg S, Morgan TM, Walton J, Chen DY, Viterbo R, Greenberg RE, Uzzo RG, Kutikov A.

BJU Int. 2013 Jul;112(2):161-8. doi: 10.1111/bju.12220.

42.

Is there a benefit to frozen section analysis at the time of partial nephrectomy?

Sterious SN, Simhan J, Smaldone MC, Tsai KJ, Canter D, Wameedh E, Li T, Helstrom J, Viterbo R, Chen DY, Greenberg RE, Kutikov A, Al-Saleem T, Uzzo RG.

Can J Urol. 2013 Jun;20(3):6778-84.

PMID:
23783047
43.

Current concepts in penile cancer.

Spiess PE, Horenblas S, Pagliaro LC, Biagioli MC, Crook J, Clark PE, Greenberg RE, Ercole CE.

J Natl Compr Canc Netw. 2013 May 1;11(5):617-24. Review.

PMID:
23667210
44.

Penile cancer: Clinical Practice Guidelines in Oncology.

Clark PE, Spiess PE, Agarwal N, Biagioli MC, Eisenberger MA, Greenberg RE, Herr HW, Inman BA, Kuban DA, Kuzel TM, Lele SM, Michalski J, Pagliaro L, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Richie JP, Sexton WJ, Shipley WU, Small EJ, Trump DL, Wile G, Wilson TG, Dwyer M, Ho M; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2013 May 1;11(5):594-615.

45.

Bladder cancer.

Clark PE, Agarwal N, Biagioli MC, Eisenberger MA, Greenberg RE, Herr HW, Inman BA, Kuban DA, Kuzel TM, Lele SM, Michalski J, Pagliaro LC, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Richie JP, Sexton WJ, Shipley WU, Small EJ, Spiess PE, Trump DL, Wile G, Wilson TG, Dwyer M, Ho M; National Comprehensive Cancer Network (NCCN).

J Natl Compr Canc Netw. 2013 Apr 1;11(4):446-75.

PMID:
23584347
46.

Clinical characteristics associated with treatment type for localized renal tumors: implications for practice pattern assessment.

Smaldone MC, Churukanti G, Simhan J, Kim SP, Reyes J, Zhu F, Kutikov A, Viterbo R, Chen DY, Greenberg RE, Uzzo RG.

Urology. 2013 Feb;81(2):269-75. doi: 10.1016/j.urology.2012.09.035.

47.

Pathological concordance and surgical outcomes of sporadic synchronous unilateral multifocal renal masses treated with partial nephrectomy.

Simhan J, Canter DJ, Sterious SN, Smaldone MC, Tsai KJ, Li T, Viterbo R, Chen DY, Greenberg RE, Kutikov A, Uzzo RG.

J Urol. 2013 Jan;189(1):43-7. doi: 10.1016/j.juro.2012.08.092. Epub 2012 Nov 16.

PMID:
23164383
48.

Role of tumor location in selecting patients for percutaneous versus surgical cryoablation of renal masses.

Long CJ, Canter DJ, Smaldone MC, Li T, Simhan J, Rozenfeld B, Teper E, Chen DY, Greenberg RE, Viterbo R, Uzzo RG, Kutikov A.

Can J Urol. 2012 Oct;19(5):6417-22. Review.

49.

Assessing performance trends in laparoscopic nephrectomy and nephron-sparing surgery for localized renal tumors.

Smaldone MC, Kutikov A, Egleston B, Simhan J, Canter DJ, Teper E, Viterbo R, Chen DY, Greenberg RE, Uzzo RG.

Urology. 2012 Aug;80(2):286-91. doi: 10.1016/j.urology.2012.02.067. Epub 2012 Jun 15.

50.

Trends in regionalization of radical cystectomy in three large northeastern states from 1996 to 2009.

Smaldone MC, Simhan J, Kutikov A, Canter DJ, Starkey R, Zhu F, Nielsen ME, Stitzenberg KB, Greenberg RE, Uzzo RG.

Urol Oncol. 2013 Nov;31(8):1663-9. doi: 10.1016/j.urolonc.2012.04.018. Epub 2012 Jun 9.

PMID:
22687566

Supplemental Content

Loading ...
Support Center